Bioithas Project
About us

Your trusted research center

An experienced team

Bioithas is a research center made up of a multidisciplinary team of pharmacists, biotechnologists, doctors and engineers, where our day to day consists of developing new probiotic combinations that improve or serve as adjuvant treatment to different pathologies.  

Based on our previous research, we test our products in clinical trials, following the same procedure as a drug, in order to obtain objective and conclusive results from our products. In addition, on many occasions, we publish our articles in the most important indexed journals in the international territory.

What we do at Bioithas

At Bioithas we focus on the study of the composition of the microbiota and its alterations associated with diseases, generating innovative products based on this knowledge: probiotics and biomarkers.  

We carry out all of this by putting great effort into conducting clinical trials with our products, which guarantee their effectiveness and quality.

In addition, we also perform services for other companies in the sector, helping to promote scientific research.

Discover our products or what services we offer:

Projects

Lines of investigation

At Bioithas we participate and lead a multitude of research projects in the field of the human microbiota. 

Some of our lines of work whose investigations have been carried out or are in progress are:

1 – Study of the efficacy of probiotics and other nutritional supplements for specific pathologies.  

Dermatology: Atopic dermatitis … 

... Psoriasis, Acne, Rosacea, Alopecia. 
Neurology: migraine, dementia. 
Oncology: breast cancer.
 Digestive: antibiotic consumption, ulcerative colitis. 
Others: COVID-19, Fibromyalgia, Overweight  

2 – Study of the composition of the intestinal microbiota: 

  1. Differences associated with body weight
  2. Changes associated with disease: ASD, Diabetes, Psoriasis, Atopic Dermatitis, Multiple sclerosis, Head and neck cancer.      

3 – Validation of microbiota-based biomarkers:

  • Multiple sclerosis
  • Head and neck cancer

Find out more information here:

Our history

Research and clinical studies

Between 2015 and 2016, Dr. Vicente Navarro, CEO and Scientific Director at Bioithas, carried out two important investigations with probiotics in skin pathologies, specifically, in psoriasis and atopic dermatitis. These scientific investigations result in two patents, which led to the need to establish Bioithas as a company. 

From that moment, several pharmaceutical laboratories became interested and contacted us to make new developments and, in parallel, we began to promote our own clinical studies in order to generate more knowledge in the field of the microbiota and, finally, new probiotic products. and its associated patents.

I + D

Our common Nexus

The human microbiota

In this field there are numerous and recent studies and investigations that relate said microbiota with the health and disease of the individual.

Currently, there is a need to find personalized treatments where a common therapy for all patients does not work correctly, which has determined the importance of looking for specific and individualized solutions. 

All of this is in the crosshairs of both technology companies and health authorities.

We use this knowledge to develop, within various pathological lines, disease biomarkers on the one hand, and on the other, probiotic products that can act by modulating this microbiota and, consequently, improving the health of the patient. “

Awards and honours

Our effort is rewarded

Our scientific research, as well as our innovative business activity for product development, has resulted in several organizations and institutions recognizing us for the great effort made:

Awards in all editions of the annual congress

since 2017

Best Start-Up Biotech

2019

Best Start-Up

2019

Horizonte 2020 SME Instrumental Phase

since 2017

Subsidies and grants

Supports they have offered us

To help us continue carrying out research projects, Bioithas has received some grants from public bodies: